J.T. Reckweg

Madrid-Gambin, F., Mallaroni, P., Haro, N., Pozo, O. J., Mason, N. L., Reckweg, J. T., Kloft-Heller, L., van Oorsouw, K., Toennes, S. W., & Ramaekers, J. G. (2026). Brain-body integromics of the ayahuasca experience. Biomedicine & Pharmacotherapy, 199, Article 119391. https://doi.org/10.1016/j.biopha.2026.119391

Ramaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L. (2025). Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug. Psychopharmacology, 242(10), 2293-2301. https://doi.org/10.1007/s00213-025-06798-8

Reckweg, J. T., Mason, N. L., Theunissen, E. L., Svendsen, C. B., Terwey, T. H., & Ramaekers, J. G. (2025). Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT. Frontiers in Psychology, 16, Article 1543640. https://doi.org/10.3389/fpsyg.2025.1543640

Prevete, E., Theunissen, E. L., Kuypers, K. P. C., Paci, R., Reckweg, J. T., Cavarra, M., Toennes, S. W., Ritscher, S., Bersani, G., Corazza, O., Pasquini, M., & Ramaekers, J. G. (2025). An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans. Psychopharmacology, 242(6), 1363-1376. https://doi.org/10.1007/s00213-024-06734-2

Ramaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L. (2025). Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study. Neuropsychopharmacology, 50(7), 1084-1092. https://doi.org/10.1038/s41386-024-02042-7

Doss, M. K., Kloft, L., Mason, N. L., Mallaroni, P., Reckweg, J. T., van Oorsouw, K., Tupper, N., Otgaar, H., & Ramaekers, J. G. (2025). Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study. Journal of Psychopharmacology, 39(4), 339-349. https://doi.org/10.1177/02698811241301216

Ramaekers, J. G., Reckweg, J. T., & Mason, N. L. (2025). Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression. American Journal of Psychiatry, 182(1), 33-46. https://doi.org/10.1176/appi.ajp.20230890

Mallaroni, P., Mason, N. L., Kloft, L., Reckweg, J. T., van Oorsouw, K., Toennes, S. W., Tolle, H. M., Amico, E., & Ramaekers, J. G. (2024). Shared functional connectome fingerprints following ritualistic ayahuasca intake. Neuroimage, 285, Article 120480. https://doi.org/10.1016/j.neuroimage.2023.120480

Mason, N. L., Szabo, A., Kuypers, K. P. C., Mallaroni, P. A., de la Torre Fornell, R., Reckweg, J. T., Tse, D. H. Y., Hutten, N. R. P. W., Feilding, A., & Ramaekers, J. G. (2023). Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study. Brain Behavior and Immunity, 114, 299-310. https://doi.org/10.1016/j.bbi.2023.09.004